Lundquist Principal Investigator Dr. Michael Yeaman awarded $11.5 million NIAID/HHS grant for innovative research to understand and solve persistent bloodstream infections
The Lundquist Institute (TLI) at Harbor-UCLA Medical Center announced today that TLI Principal Investigator, Michael Yeaman, PhD, has been awarded ...